サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1404882

新膣形成術の市場規模、シェア、動向分析レポート：治療タイプ別、地域別、セグメント予測、2024年～2030年

Neovaginal Surgery Market Size, Share & Trends Analysis Report By Treatment Type (Vaginal Agenesis Treatment Surgery, Vaginal Atresia Treatment Surgery, Sex Reassignment Surgery), By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
新膣形成術の市場規模、シェア、動向分析レポート：治療タイプ別、地域別、セグメント予測、2024年～2030年
出版日: 2023年11月06日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

新膣形成術市場の成長と動向：

Grand View Research社の最新レポートによると、世界の新膣形成術市場規模は2030年までに16億7,000万米ドルに達する見込みです。

同市場は2024年から2030年にかけてCAGR 5.04％で成長すると予測されています。市場の主な促進要因は、これらの手術を支援する保険や政府の償還政策、トランスジェンダーに対する社会的受容の拡大です。研究者たちは、従来の皮膚移植に代わる革新的な新膣形成術の開発に注力しています。このような技術革新により、従来の手術方法よりも効率的かつ低コストで手術を行うことができるようになった。

自分の身体的特徴を性自認に一致させるために、性転換手術（SRS）を選択する人もいます。マウントサイナイ病院トランスジェンダー医療外科センターの2021年の年次報告書によると、25歳から34歳までのトランスジェンダー人口の約41.7％、15歳から24歳までのトランスジェンダー人口の約25.8％が、性別適合手術（SRS）を受けています。マウントサイナイ病院では約861件のSRSが行われ、そのうち639件が特に女性化を目的としたものでした。25歳から34歳の男性化した人々は、性別適合手術を受ける傾向が強く、実施された女性化手術全体の約41％を占めています。

新膣形成術市場レポートハイライト：

  • 同市場は、男性から女性への手術件数の多さと保険政策の利用可能性により、大幅な成長が予測されます。さらに、医療従事者は手術時間を短縮するために革新的な新膣形成術技術を開発しています。
  • 治療タイプ別では、男性から女性への性転換（MtF）手術の需要が増加していることから、性転換手術セグメントが2023年の市場を独占しました。
  • アジア太平洋地域は、新膣形成術の利用可能性に関する意識の高まりにより、2023年の市場を独占しました。低価格で治療が受けられるなどの要因により、外国人患者の流入が増加している国もあります。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTLE分析
  • COVID-19感染症の影響分析
  • 新膣形成術：公立病院vs.私立病院
  • 償還シナリオ

第4章 新膣形成術市場：治療タイプの分析

  • 新膣形成術市場の治療タイプの変動分析、2023年および2030年
  • 治療タイプ別
    • 膣形成不全治療手術
    • 膣閉鎖症治療手術
    • 性別適合手術

第5章 新膣形成術市場：地域分析

  • 新膣形成術の地域市場シェア分析、2023年および2030年
  • 地域市場のスナップショット（市場規模、 CAGR）
  • 北米
    • 北米新膣形成術市場、2018年から2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州新膣形成術市場、2018年から2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • アジア太平洋地域の新膣形成術市場、2018年から2030年
    • 日本
    • 中国
    • インド
    • タイ
    • インドネシア
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカ新膣形成術市場、2018年から2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東とアフリカ
    • 中東およびアフリカの新膣形成術市場、2018年から2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合分析

  • 企業の分類
  • 企業の市況分析
  • 戦略マッピング
    • 合併・買収
    • コラボレーション
    • 新製品の発売
  • 企業プロファイル
    • London Transgender Clinic
    • Phuket Plastic Surgery Institute（Bangkok Hospital Siriroj）
    • Icahn School of Medicine at Mount Sinai
    • Cedars-Sinai
    • Nationwide Children's Hospital
    • Ann &Robert H. Lurie Children's Hospital of Chicago（Lurie Children's）
    • CHETTAWUT PLASTIC SURGERY CENTER
    • Tips viz. Tricity Institute of Plastic Surgery
    • Gonzalez-Fontana
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 4 Global Neovaginal Surgery Market, by Region, 2018 - 2030 (USD Million)
  • Table 5 North America Neovaginal Surgery Market, by Country, 2018 - 2030 (USD Million)
  • Table 6 North America Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 7 US Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 8 Canada Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 9 Europe Neovaginal Surgery Market, by Country, 2018 - 2030 (USD Million)
  • Table 10 Europe Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 11 UK Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 12 France Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 13 Italy Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 14 Spain Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 15 Norway Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 16 Sweden Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 17 Denmark Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific Neovaginal Surgery Market, by Country, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 20 China Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 21 Japan Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 22 India Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 23 South Korea Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 24 Thailand Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 25 Indonesia Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 26 Latin America Neovaginal Surgery Market, by Country, 2018 - 2030 (USD Million)
  • Table 27 Latin America Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 28 Brazil Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 29 Mexico Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 30 Argentina Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 31 Middle East & Africa Neovaginal Surgery Market, by Country, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 33 South Africa Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 34 Saudi Arabia Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 35 UAE Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 36 Kuwait Neovaginal Surgery Market, by Treatment Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Neovaginal surgery market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Market segmentation (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Neovaginal surgery market lineage
  • Fig. 13 Related market outlook
  • Fig. 14 Neovaginal surgery market dynamics
  • Fig. 15 Neovaginal surgery market: Porter's five forces analysis
  • Fig. 16 Neovaginal surgery market: PESTLE analysis
  • Fig. 17 Neovaginal surgery market: Treatment type movement share analysis, (USD Million)
  • Fig. 18 Neovaginal surgery treatment type market outlook: Key takeaways
  • Fig. 19 Vaginal agenesis treatment surgery market, 2018 - 2030 (USD Million)
  • Fig. 20 Vaginal atresia treatment surgery market 2018 - 2030 (USD Million)
  • Fig. 21 McIndoe technique market 2018 - 2030 (USD Million)
  • Fig. 22 Vecchietti technique market 2018 - 2030 (USD Million)
  • Fig. 23 Sex reassignment surgery market 2018 - 2030 (USD Million)
  • Fig. 24 Regional marketplace: Key takeaways
  • Fig. 25 North America neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 26 Key country dynamics
  • Fig. 27 US neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 28 Key country dynamics
  • Fig. 29 Canada neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 30 Key country dynamics
  • Fig. 31 Europe neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 32 Key country dynamics
  • Fig. 33 UK neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 Germany neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 36 Key country dynamics
  • Fig. 37 France neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 Italy neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Spain neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Sweden neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Norway neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Denmark neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Japan neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 China neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 India neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Thailand neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Indonesia neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 South Korea neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 61 Latin America neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Brazil neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Mexico neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Argentina neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 68 Middle East & Africa neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 South Africa neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Saudi Arabia neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 UAE neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Kuwait neovaginal surgery market, 2018 - 2030 (USD Million)
  • Fig. 77 Company/competition categorization
  • Fig. 78 Company market position analysis
  • Fig. 79 Strategy mapping
目次
Product Code: GVR-4-68039-290-4

Neovaginal Surgery Market Growth & Trends:

The global neovaginal surgery market size is expected to reach USD 1.67 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 5.04% from 2024 to 2030. The primary drivers of the market are insurance and government reimbursement policies that offer support for these surgeries, and the increasing social acceptance of transgender individuals. Researchers are concentrating on creating innovative alternatives to traditional skin grafts for neovaginal construction. These innovations enable the procedure to be performed more efficiently and at a lower cost than conventional surgical methods.

Certain individuals choose Sex Reassignment Surgery (SRS) to bring their physical characteristics in line with their gender identity. As per the 2021 annual report from the Mount Sinai Center for Transgender Medicine and Surgery, approximately 41.7% of individuals within the transfeminine population between the ages of 25 and 34, and 25.8% within the age group of 15 to 24, have undergone Sex Reassignment Surgery (SRS). The Mount Sinai Hospital carried out approximately 861 SRS, with 639 specifically geared toward feminization. Individuals within the transmasculine population between the ages of 25 and 34 are more inclined to undergo gender-affirming surgeries, constituting approximately 41% of all the transfeminine surgeries performed.

Neovaginal Surgery Market Report Highlights:

  • The market is projected to witness significant growth, owing to the high number of Male-to-Female surgeries and the availability of insurance policies. Moreover, medical practitioners are creating innovative neovaginal surgery techniques to reduce surgery time
  • Based on the treatment type, the sex reassignment surgery segment dominated the market in 2023 owing to the increasing demand for Male-to-Female (MtF) procedures
  • Asia Pacific dominated the market in 2023 due to the increasing awareness regarding the availability of neovaginal surgeries. Few destinations witnessed an increased influx of foreign patients due to factors such as the availability of treatments at low-cost

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Treatment Type
    • 1.1.2. Region
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
    • 1.3.1. Information procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
    • 1.3.6. Details of Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
    • 1.5.1. Volume Price Analysis
  • 1.6. List of Secondary Sources
  • 1.7. List of Abbreviations
  • 1.8. Research Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. PORTER'S Five Forces Analysis
    • 3.3.2. PESTLE Analysis
  • 3.4. COVID-19 Impact Analysis
  • 3.5. Neovaginal Surgery: Public Hospitals vs. Private Hospitals
  • 3.6. Reimbursement Scenario

Chapter 4. Neovaginal Surgery Market: Treatment Type Analysis

  • 4.1. Neovaginal Surgery Market Treatment Type Movement Analysis, 2023 & 2030
  • 4.2. Neovaginal Surgery Market Estimates & Forecasts, By Treatment Type (USD Million)
    • 4.2.1. Vaginal Agenesis Treatment Surgery
      • 4.2.1.1. Vaginal agenesis treatment surgery market, 2018 - 2030 (USD Million)
    • 4.2.2. Vaginal Atresia Treatment Surgery
      • 4.2.2.1. Vaginal atresia treatment surgery market, 2018 - 2030 (USD Million)
      • 4.2.2.2. McIndoe technique
      • 4.2.2.2.1. McIndoe technique market, 2018 - 2030 (USD Million)
      • 4.2.2.3. Vecchietti Technique
      • 4.2.2.3.1. Vecchietti technique market, 2018 - 2030 (USD Million)
    • 4.2.3. Sex Reassignment Surgery
      • 4.2.3.1.1. Sex reassignment surgery market, 2018 - 2030 (USD Million)

Chapter 5. Neovaginal Surgery Market: Regional Analysis

  • 5.1. Neovaginal Surgery Regional Market Share Analysis, 2023 & 2030
  • 5.2. Regional Market Snapshot (Market Size, CAGR)
  • 5.3. North America
    • 5.3.1. North America Neovaginal Surgery Market, 2018 - 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. U.S. neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Canada neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Europe Neovaginal Surgery Market, 2018 - 2030 (USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Germany neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.4.3. UK
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. UK neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. France neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Italy neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Spain neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Norway neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Key country dynamics
      • 5.4.9.2. Regulatory framework
      • 5.4.9.3. Competitive scenario
      • 5.4.9.4. Denmark neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific Neovaginal Surgery Market, 2018 - 2030 (USD Million)
    • 5.5.2. Japan
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. Japan neovaginal surgery market, 2018 - 2030 (USD Million).
    • 5.5.3. China
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. China neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. India neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. Thailand neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.5.6. Indonesia
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Indonesia neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. Key country dynamics
      • 5.5.7.2. Regulatory framework
      • 5.5.7.3. Competitive scenario
      • 5.5.7.4. South Korea neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America Neovaginal Surgery Market, 2018 - 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Brazil neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.6.3. Mexico
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. Mexico neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.6.4. Argentina
      • 5.6.4.1. Key country dynamics
      • 5.6.4.2. Regulatory framework
      • 5.6.4.3. Competitive scenario
      • 5.6.4.4. Argentina neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.7. Middle East & Africa
    • 5.7.1. Middle East & Africa Neovaginal Surgery Market, 2018 - 2030 (USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. South Africa neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.7.3. Saudi Arabia
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. Saudi Arabia neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. UAE neovaginal surgery market, 2018 - 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Regulatory framework
      • 5.7.5.3. Competitive scenario
      • 5.7.5.4. Kuwait neovaginal surgery market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Analysis

  • 6.1. Company Categorization
  • 6.2. Company Market Position Analysis
  • 6.3. Strategy Mapping
    • 6.3.1. Merger& Acquisition
    • 6.3.2. Collaborations
    • 6.3.3. New Product Launch
  • 6.4. Company Profiles
    • 6.4.1. London Transgender Clinic
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. Phuket Plastic Surgery Institute (Bangkok Hospital Siriroj)
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. Icahn School of Medicine at Mount Sinai
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. Cedars-Sinai
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Nationwide Children's Hospital
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. Ann & Robert H. Lurie Children's Hospital of Chicago (Lurie Children's)
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. CHETTAWUT PLASTIC SURGERY CENTER
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Tips viz. Tricity Institute of Plastic Surgery
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. Gonzalez-Fontana
      • 6.4.9.1. Company overview
      • 6.4.9.2. Financial performance
      • 6.4.9.3. Product benchmarking
      • 6.4.9.4. Strategic initiatives